Enriched hits from the CRISPR growth screen were significantly enriched in negative regulator of cell growth. Top: Venn diagram showing a total of 112 hits were commonly enriched in both HCCLM3 and SNU449 cell lines at the end of the screen. Bottom: KEGG pathway analysis showing significant enrichment in mTOR signaling and p53 signaling pathways which function as negative regulators of cell growth, amongst these 112 commonly enriched targets. The x-axis shows the p value from hypergeometric test adjusted by the multiple test correction. The dash line indicates a threshold of corrected p value=0.05. were arrested at G1 phase using double thymidine method and released into normal growth media. Upper panel: Cells were harvested at various time points 0-24 hours post release and cell cycle profile were analyzed using PI staining and FACS analysis. Bottom panel: NCAPG protein expression was analyzed in the same cells using western blot analysis with GAPDH as endogenous control. Supplementary Fig. S4 NCAPG is found to be frequently up-regulated in most cancers. Boxplot of NCAPG transcript measured using RNA-seq in 36 different cancer types from TCGA datasets showed significant up-regulation of NCAPG in tumor (red boxes) versus matching normal samples (blue boxes) in majority of cancers.

